Does adjuvant steroid therapy post-Kasai portoenterostomy improve the outcome of biliary atresia? A systematic review and meta-analysis

Canadian Journal of Gastroenterology

Volumn 25, Issue 8, 2011, Pages 440-444

  Sarkhy, Ahmed ^a   Schreiber, Richard A ^b   Milner, Ruth ^b   Barker, Collin C ^b  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Biliary atresia; Corticosteroids; Kasai portoenterostomy; Liver transplantation; Systematic review

Indexed keywords

CHOLERETIC AGENT; METHYLPREDNISOLONE; PREDNISOLONE; STEROID; BILIRUBIN; GLUCOCORTICOID;

ADJUVANT THERAPY; BILE DUCT ATRESIA; BILIRUBIN BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; HUMAN; LIVER TRANSPLANTATION; META ANALYSIS; NUTRITIONAL SUPPORT; PORTOENTEROSTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STEROID THERAPY; SYSTEMATIC REVIEW; TREATMENT DURATION; ADJUVANT CHEMOTHERAPY; BLOOD; METHODOLOGY; TREATMENT OUTCOME;

BILIARY ATRESIA; BILIRUBIN; CHEMOTHERAPY, ADJUVANT; GLUCOCORTICOIDS; HUMANS; LIVER TRANSPLANTATION; PORTOENTEROSTOMY, HEPATIC; TREATMENT OUTCOME;

EID: 80053330976     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2011/125610     Document Type: Review

References (34)

1. Sokol RJ, Shepherd RW, Superina R, Bezzera J, Robuck P, Hoofnagle J. Screening and outcomes in biliary atresia: Summary of a National Institutes of Health Workshop. Hepatology 2007;46:566-581. (Pubitemid 47344793)
2. Sokol RJ, Mack C. Etiopathogenesis of biliary atresia. Semin Liver Dis 2001;21:517-24. (Pubitemid 33131043)
3. Chitsaz E, Schreiber R, Collet JP and Kaczorowski J. Biliary atresia: The timing needs a changin'. Can J Pub Health 2009;100:475-77.
4. Hartley JL, Davenport M, Kelly DA. Biliary atresia. Lancet 2009;14:1704-13.
5. Schreiber RA, Barker CC, Roberts EA, et al. Canadian Pediatric Hepatology Research Group. Biliary atresia: The Canadian experience. J Pediatr 2007;151:659-65.
6. Serinet MO, Wildhaber BE, Broue P, et al. Impact of age at Kasai operation on its results in late childhood and adolescence: A rationale basis for biliary atresia screening. Pediatrics 2009;123:1280-6.
7. Schreiber RA, Barker CC, Roberts EA, Martin S. Biliary atresia in Canada: The effect of centre caseload experience on outcome. JPGN 2010;51:61-5.
8. Balisteri WF, Grand R, Hoofnagle J, et al. Biliary atresia; current concepts and research direction: Summary of a symposium. Hepatology 1996;23:1682-92.
9. Karrer FM, Lilly JE. Corticosteroid therapy in biliary atresia. J Pediatr Surg 1985;20:693-5. (Pubitemid 16175622)
10. Muraji T, Higashimoto Y. The improved outlook for biliary atresia with corticosteroid therapy. J Pediatr Surg 1997;32:1103-7. (Pubitemid 27349034)
11. Dillon PW, Owings E, Cilley R, Field D, Curnow A, Georgeson K. Immunosuppression as adjuvant therapy for biliary atresia. J Pediatr Surg 2001;36:80-5. (Pubitemid 32044319)
12. Meyers R, Book LS, O'Gorman MA, et al. High-dose steroids, ursodeoxycholic acid, and chronic intravenous antibiotics improve bile flow after Kasai procedure in infants with biliary atresia. J Pediatr Surg 2003;38:406-11. (Pubitemid 36278701)
13. Muraji T, Nio M, Ohhama Y, et al. Japanese Biliary Atresia Society. Postoperative corticosteroid therapy for bile drainage in biliary atresia - a nationwide survey. J Pediatr Surg 2004;39:1803-5. (Pubitemid 40017722)
14. Kobayashi H, Yamataka A, Koga H, et al. Optimum prednisolone usage in patients with biliary atresia postportoenterostomy. J Pediatr Surg 2005;40:327-33.
15. Tatekawa Y, Muraji T, Tsugawa C. Glucocorticoid receptor alpha expression in the intrahepatic biliary epithelium and adjuvant steroid therapy in infants with biliary atresia. J Pediatr Surg 2005;40:1574-80. (Pubitemid 41530118)
16. Escobar MA, Jay CL, Brooks RM, et al. Effect of corticosteroid therapy on outcomes in biliary atresia after Kasai portoenterostomy. J Pediatr Surg 2006;41:99-103. (Pubitemid 43067500)
17. Shimadera S, Iwai N, Deguchi E, Kimura O, Fumino S, Ono S. The significance of steroid therapy after hepatoportoenterostomy in infants with biliary atresia. Eur J Pediatr Surg 2007;17:100-3. (Pubitemid 47262569)
18. Vejchapipat P, Passakonnirin R, Sookpotarom P, Chittmittrapap S, Poovorawan Y. High-dose steroids do not improve early outcome in biliary atresia. J Pediatr Surg 2007;42:2102-5. (Pubitemid 350235516)
19. Stringer MD, Davison SM, Rajwal SR, McClean P. Kasai portoenterostomy: 12-year experience with a novel adjuvant therapy regimen. J Pediatr Surg 2007;42:1324-8. (Pubitemid 47238318)
20. Foroutan H.R, Hosseini A.H. Dehghani S.M, et al. Peri-operative high-dose v post-operative low dose steroid therapy in the management of biliary atresia: A preliminary report. Iran J Med Sci 2008;33:79-83.
21. Shimadera S, Iwai N, Deguchi E, et al. Significance of ductal plate malformation in the postoperative clinical course of biliary atresia. J Pediatr Surg 2008;43:304-7. (Pubitemid 351226220)
22. Petersen C, Harder D, Melter M, et al. Postoperative high-dose steroids do not improve mid-term survival with native liver in biliary atresia. Am J Gastroenterol 2008;103:712-9. (Pubitemid 351406001)
23. Chung HY, Kak Yuen Wong K, Cheun Leung Lan L, Kwong Hang Tam P. Evaluation of a standardized protocol in the use of steroids after Kasai operation. Pediatr Surg Int 2008;24:1001-4.
24. Lao OB, Larison C, Garrison M, Healey PJ, Goldin AB. Steroid use after the Kasai procedure for biliary atresia. Am J Surg 2010;199:680-4.
25. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Department of Epidemiology and Community Medicine, University of Ottawa, Canada. 〈www.ohri.ca/programs/clinical-epidemiology/oxford.asp〉(Accessed on November 27, 2010).
26. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996;17:1-12. (Pubitemid 26120810)
27. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88. (Pubitemid 17189972)
28. Davenport M, Stringer MD, Tizzard SA, McClean P, Mieli-Vergani G, Hadzic N. Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia. Hepatology 2007;46:1821-7.
29. Sutton AJ, Duval SJ, Tweedie RL, Abrams KR, Jones DR. Empirical assessment of effect of publication bias on meta-analyses. BMJ 2000;320:1574-7. (Pubitemid 30336090)
30. Kasai M, Suzuki S. [A new operation for "non-correctable" biliary atresia: Hepatic portoenterostomy.] Shujutsu 1959;13:733-9.
31. Rodeck B, Becker AC, Gratz KF, Petersen C. Early predictors of Success of Kasai operation in children with biliary atresia. Eur J Pediatr Surg 2007;17:308-12. (Pubitemid 350144567)
32. Shneider B, Brown MB, Haber B, et al. A multicenter study of the outcome of biliary atresia in the United States,1997-2000. J Peds 2006;148:467-74.
33. Lilly JR, Karrer FM, Hall RJ, et al. The surgery of biliary atresia. Ann Surg 1989;210:289-94.
34. A randomized double-blinded, placebo controlled trial of corticosteroid therapy following portoenterostomy. 〈http://clinicaltrials.gov/ct2/show/ NCT00294684?term=biliary+atresia+and+US&rank=2〉(Accessed on November 18, 2010).